Drug Shortage Report for SANDOZ LACOSAMIDE
Report ID | 225218 |
Drug Identification Number | 02474689 |
Brand name | SANDOZ LACOSAMIDE |
Common or Proper name | LACOSAMIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | LACOSAMIDE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60FCT |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-04-15 |
Estimated end date | 2024-06-28 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-04-16 | French | Compare |
v1 | 2024-04-16 | English | Compare |
Showing 1 to 2 of 2